TY - JOUR
T1 - Proceedings of the Second Annual Deep Brain Stimulation Think Tank
T2 - What's in the Pipeline
AU - Gunduz, Aysegul
AU - Morita, Hokuto
AU - Rossi, P. Justin
AU - Allen, William L.
AU - Alterman, Ron L.
AU - Bronte-Stewart, Helen
AU - Butson, Christopher R.
AU - Charles, David
AU - Deckers, Sjaak
AU - De Hemptinne, Coralie
AU - Delong, Mahlon
AU - Dougherty, Darin
AU - Ellrich, Jens
AU - Foote, Kelly D.
AU - Giordano, James
AU - Goodman, Wayne
AU - Greenberg, Benjamin D.
AU - Greene, David
AU - Gross, Robert
AU - Judy, Jack W.
AU - Karst, Edward
AU - Kent, Alexander
AU - Kopell, Brian
AU - Lang, Anthony
AU - Lozano, Andres
AU - Lungu, Codrin
AU - Lyons, Kelly E.
AU - MacHado, Andre
AU - Martens, Hubert
AU - McIntyre, Cameron
AU - Min, Hoon Ki
AU - Neimat, Joseph
AU - Ostrem, Jill
AU - Pannu, Sat
AU - Ponce, Francisco
AU - Pouratian, Nader
AU - Reymers, Donnie
AU - Schrock, Lauren
AU - Sheth, Sameer
AU - Shih, Ludy
AU - Stanslaski, Scott
AU - Steinke, G. Karl
AU - Stypulkowski, Paul
AU - Troster, Alexander I.
AU - Verhagen, Leo
AU - Walker, Harrison
AU - Okun, Michael S.
N1 - Funding Information:
AG: Grant support from Medtronic, Inc.; HK: None; PJR: None; WLA: None; RLA: Consultant for Medtronic, Inc.; HB-S: None; CRB: Consultant for St Jude Medical, Boston Scientific; IP related to DBS; DC: Vanderbilt receives income from grants or contracts from Allergan, Ipsen, Merz and Medtronic for research led by DC; DC receives income from Allergan, Ipsen, Medtronic and, the Alliance for Patient Access for education or consulting services; SD: Employee and shareholder of Sapiens Steering Brain Stimulation GmbH (Medtronic Eindhoven Design Center); CDH: None; MDL: None; DD: Grant support from Medtronic, Cyberonics, Eli Lilly, Roche, Honoraria from Medtronic, Insys, Johnson & Johnson; JE: Chief Medical Officer at Sapiens Steering Brain Stimulation GmbH; KDF: Grant support from Medtronic, St. Jude, Boston Scientific, Neuropace; Consultant for Medtronic, Neuropace; JG: None; WG: None; BDG: None; DG: Employee of Neuropace; RG: None; JJ: None; EK: Employee of St. Jude Medical; AK: Employee of St. Jude Medical; BK: Consultant for Medtronic, St Jude Neuromodulation, MRI Interventions; ALang: Consultant for Abbvie, Allon Therapeutics, Avanir Pharmaceuticals, Biogen Idec, Boerhinger-Ingelheim, Ceregene, Lilly, Medtronic, Merck, Novartis, NeuroPhage Pharmaceuticals, Teva, UCB; Honoraria from Medtronic, Teva, UCB, AbbVie; Grant support from Brain Canada, Canadian Institutes of Health Research, Edmond J Safra Philanthropic Foundation, Michael J. Fox Foundation, the Ontario Brain Institute, National Parkinson Foundation, Parkinson Society Canada, Tourette Syndrome Association, W. Garfield Weston Foundation; Publishing royalties from Saunders, Wiley-Blackwell, Johns Hopkins Press, Cambridge University Press; ALozano: Consultant for Medtronic, St Jude and Boston Scientific, Co-Founder of Functional Neuromodulation; CL: None; KL: Consultant for Medtronic, St. Jude Medical; AM: IP in Enspire, ATI, Cardionomics, Grant support from Medtronic, Inc., Consultant for Functional Neuro-modulation, Spinal Modulation; HM: Employee and shareholder of Sapiens Steering Brain Stimulation GmbH (Medtronic Eindhoven Design Center); CM: IP in Boston Scientific Neuromodulation; Consultant for Boston Scientific Neuromodulation; Shareholder in Autonomic Technologies, Inc., Cardionomics, Inc., Neuros Medical, Inc., Surgical Information Sciences, Inc.; BM: None; HKM: None; JN: Grant support from Medtronic, Inc.; Consultant for Medtronic, Inc., Mon-teris Inc.; JO: Grant support from Boston Scientific, MRI Interventions, St Jude Medical, Medtronic; SP: None; FP: Consultant for Medtronic, Inc; NP: None; DR: Employee of Neuromodulation, Inc; LSchrock: Site PI for the Boston Scientific INTREPID DBS trial; SSheth: None; LShih: None; SStanslanski: Employee of Medtronic, Inc.; GKS: Employee of Boston Scientific Neuromodulation; PS: Employee of Medtronic, Inc.; AT: Consultant for St Jude Medical, Boston Scientific, Theravance, Teva; Grant support from Glaxo Smith Kone, Speaker for Medtronic; Royalties from Oxford University Press; LV: None; HW: None; MSO: Consultant for National Parkinson Foundation; Grant support from NIH, NPF, Michael J. Fox Foundation, Parkinson Alliance, Smallwood Foundation, Bachmann-Strauss Foundation, Tourette Syndrome Association, UF Foundation.
Publisher Copyright:
© 2015 The Authors.
PY - 2015/7/3
Y1 - 2015/7/3
N2 - The proceedings of the 2nd Annual Deep Brain Stimulation Think Tank summarize the most contemporary clinical, electrophysiological, and computational work on DBS for the treatment of neurological and neuropsychiatric disease and represent the insights of a unique multidisciplinary ensemble of expert neurologists, neurosurgeons, neuropsychologists, psychiatrists, scientists, engineers and members of industry. Presentations and discussions covered a broad range of topics, including advocacy for DBS, improving clinical outcomes, innovations in computational models of DBS, understanding of the neurophysiology of Parkinson's disease (PD) and Tourette syndrome (TS) and evolving sensor and device technologies.
AB - The proceedings of the 2nd Annual Deep Brain Stimulation Think Tank summarize the most contemporary clinical, electrophysiological, and computational work on DBS for the treatment of neurological and neuropsychiatric disease and represent the insights of a unique multidisciplinary ensemble of expert neurologists, neurosurgeons, neuropsychologists, psychiatrists, scientists, engineers and members of industry. Presentations and discussions covered a broad range of topics, including advocacy for DBS, improving clinical outcomes, innovations in computational models of DBS, understanding of the neurophysiology of Parkinson's disease (PD) and Tourette syndrome (TS) and evolving sensor and device technologies.
KW - Deep brain stimulation
KW - Electrophysiology
KW - Movement disorders
KW - Neuroethics
KW - neurotechnology
UR - http://www.scopus.com/inward/record.url?scp=84938678853&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938678853&partnerID=8YFLogxK
U2 - 10.3109/00207454.2014.999268
DO - 10.3109/00207454.2014.999268
M3 - Review article
C2 - 25526555
AN - SCOPUS:84938678853
SN - 0020-7454
VL - 125
SP - 475
EP - 485
JO - International Journal of Neuroscience
JF - International Journal of Neuroscience
IS - 7
ER -